Home - Products - Apoptosis - TNF - Physcion 8-O-β-D-glucopyranoside

Physcion 8-O-β-D-glucopyranoside

CAS No. 23451-01-6

Physcion 8-O-β-D-glucopyranoside( Physcion 8-O-beta-D-monoglucoside )

Catalog No. M29212 CAS No. 23451-01-6

Physcion 8-O-β-D-glucopyranoside has anti-inflammatory and anti-cancer activities. Physcion 8-O-β-D-glucopyranoside can be used in studies about common malignancy cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 176 Get Quote
10MG 266 Get Quote
25MG 447 Get Quote
50MG 651 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Physcion 8-O-β-D-glucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Physcion 8-O-β-D-glucopyranoside has anti-inflammatory and anti-cancer activities. Physcion 8-O-β-D-glucopyranoside can be used in studies about common malignancy cancer.
  • Description
    Physcion 8-O-β-D-glucopyranoside has anti-inflammatory and anti-cancer activities. Physcion 8-O-β-D-glucopyranoside can be used in studies about common malignancy cancer.(In Vitro):Physcion 8-O-β-D-glucopyranoside inhibits TNF-α±-induced cytotoxicity and apoptosis in L929 cells via TNF-R1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Physcion 8-O-beta-D-monoglucoside
  • Pathway
    Apoptosis
  • Target
    TNF
  • Recptor
    TNF
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23451-01-6
  • Formula Weight
    446.408
  • Molecular Formula
    C22H22O10
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (56.00 mM)
  • SMILES
    COc1cc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2C(=O)c3c(O)cc(C)cc3C(=O)c2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Zigakibart

    Zigakibart (BION-1301) is a humanized monoclonal antibody targeting TNFSF13 with anti-inflammatory activity for the study of immunoglobulin A nephropathy (IgAN).

  • SPD304

    SPD304 is a selective TNF-α inhibitor and blocks the interaction of TNF and its receptor. SPD304 has an IC50 of 22 μM for inhibiting in vitro TNF receptor 1 binding to TNF-α.

  • Ragifilimab

    Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody that targets glucocorticoid-induced TNFR-associated protein (GITR) and can be used in the study of advanced or metastatic solid tumors.